Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
R&D Expense Growth
12.61%
Quarterly · Period ending:
TEVA R&D Expense Growth
Latest reported12.61%period ending
Latest reported12.61%period ending
TEVA Quarterly R&D Growth (QoQ) (0.00% → 12.61%)
Latest values, visible window
High-resolution chart · PNG
TEVA r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -3.1431% | |
| -8.8607% | |
| 11.1433% | |
| 5.127% | |
| 31.9681% | |
| -8.7858% | |
| 11.4388% | |
| -7.9812% | |
| 10.9375% | |
| 20.7547% | |
| -21.6749% | |
| 25.3086% | |
| 3.1847% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |